MARS services include: training in medication assisted recovery, a mix of culturally appropriate support groups, drug and alcohol free social activities, recovery celebratory events, peer leader training and mentoring, and a peer council to help direct the development of the project. The most important part of MARS is the Core Training in Addiction and how…

Big Smiles on Joergen’s Face as he Calls the Group to Order Read Joergen Kjaer’s Speech (Danish) Thank You for Being Our Friend Charlotte Fich receives the Users Friend of the Year Award. An special nurse she helps users with health and injection issues and does so with compassion. This is the 7th year that…

Policy Statement Number 9 August 2002 There are many misperceptions and misunderstanding about the federal regulations and particularly when it comes to issues regarding raising the dose over 100 mgs. Prior to the HIV epidemic in order to raise a patient’s dose it was required for the physician to contact the Food and Drug Administration…

What Did You Do  For NAMA Today? Vermont Patient Denied Medication Despite Court Order Three years ago Keith Griggs, 40, was a strung out homeless addict. Today, after getting on a methadone program, Keith and his wife Tammy have worked hard at building a new life for themselves and their two children. Keith also just…

National Alliance of Methadone Advocates The President’s Office Joycelyn Woods Executive Report DRAFT New York State Regulations, Page 4 of 5 Go to Page 5

FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…